GlassScriptPhysician profile
Ralph B Pfeiffer
NPI 1063415339
$1,573.77
in general payments reported to CMS, 2019-2025
15 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.42 · 2020: $68.62 · 2021: $102 · 2022: $763 · 2023: $289 · 2024: $152 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $913.01 | 2022-2023 | Puraply |
| Cook Medical LLC | $199.88 | 2019-2024 | Zenith Spiral-Z |
| Medtronic, INC. | $59.67 | 2021 | |
| Allergan, INC. | $59.14 | 2019 | |
| Angiodynamics, INC. | $56.38 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Kerecis Limited | $55.37 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $45.93 | 2021-2025 | Renasys Touch |
| Baxter Healthcare | $45.02 | 2020 | |
| Cagent Vascular INC | $28.86 | 2025 | Serrantor |
| Janssen Pharmaceuticals, INC | $25.83 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.37 | 2023 | |
| Dilon Technologies, INC. | $18.58 | 2025 | Hemoblast Bellows |
| Cardiva Medical, INC. | $17.79 | 2025 | Cardiva Vascade 6/7f Vcs |
| Vifor Pharma, INC. | $13.04 | 2022 | |
| Paratek Pharmaceuticals, INC. | $12.90 | 2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Pfeiffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.